MYGN Operating Income
-$98.60MTTM · USD
Period ending:
MYGN FY Operating IncomeUSD
$274.40M-$231.70M
1996-06-302025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
MYGN operating income history
Profit from core business operations before interest and taxes. The available annual fiscal periods series contains 31 observations from Jun 30, 1996 to Dec 31, 2025.
| Period ending | Operating Income (USD) |
|---|---|
| -67,800,000 | |
| -88,000,000 | |
| -144,600,000 | |
| -123,700,000 | |
| -190,500,000 | |
| -194,800,000 | |
| -231,700,000 | |
| 7,600,000 | |
| 121,900,000 | |
| 44,000,000 | |
| 153,400,000 | |
| 134,200,000 | |
| 274,400,000 | |
| 228,000,000 | |
| 180,318,000 | |
| 157,778,000 | |
| 135,075,000 | |
| 126,462,000 | |
| 61,605,000 | |
| -47,727,000 | |
| -45,589,000 | |
| -40,745,000 | |
| -42,635,000 | |
| -27,346,000 | |
| -18,659,767 | |
| -13,136,505 | |
| -11,547,127 | |
| -12,400,000 | |
| -13,000,000 | |
| -12,500,000 | |
| -8,900,000 |
Compare operating income
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) operating income
- Bridgebio Pharma Inc (BBIO) operating income
- Brightspring Health Services Inc (BTSG) operating income
- Madrigal Pharmaceuticals Inc (MDGL) operating income
- Ensign Group Inc (ENSG) operating income
- Glaukos Corp (GKOS) operating income
- Vaxcyte Inc (PCVX) operating income
- Krystal Biotech Inc (KRYS) operating income
All MYGN financial metrics · MYGN stock overview · How to interpret financial metrics